| Previous close | 2.6100 |
| Open | 2.9000 |
| Bid | 2.0000 |
| Ask | 2.9000 |
| Strike | 3.00 |
| Expiry date | 2024-12-20 |
| Day's range | 2.6100 - 2.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 710 |
PR NewswireVanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies 2024 Global Healthcare Conference in New York City on Thursday, June 6, 2024. A corporate presentation is scheduled for 2:00 p.m. Eastern Time.
- PR Newswire
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug Application and Investigational New Drug Applications for PONVORY® (ponesimod) has been transferred to Vanda from a Johnson & Johnson Company, which now fully allows Vanda to commercialize PONVORY® in the U.S.
- PR Newswire
Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2024, to be held in Houston, TX from June 1 through June 5, 2024.
© 2024 Yahoo. All rights reserved.